William H. Ludlam

Endocrinology

550 17th Ave Ste 500
Seattle, WA 98122

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 27 publications

Durable biochemical response and safety with oral octreotide capsules in acromegaly.

Durable biochemical response and safety with oral octreotide capsules in acromegaly.

Journal: European journal of endocrinology

Published: March 16, 2022

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.

Correction to: Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.

Journal: Pituitary

Published: August 04, 2021

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial.

Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial.

Journal: The lancet. Diabetes & endocrinology

Published: July 29, 2021

Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.

Oral octreotide capsules for the treatment of acromegaly: comparison of 2 phase 3 trial results.

Journal: Pituitary

Published: June 11, 2021

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands.

Disease and Treatment-Related Burden in Patients With Acromegaly Who Are Biochemically Controlled on Injectable Somatostatin Receptor Ligands.

Journal: Frontiers in endocrinology

Published: November 10, 2020

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide.

Maintenance of Acromegaly Control in Patients Switching From Injectable Somatostatin Receptor Ligands to Oral Octreotide.

Journal: The Journal of clinical endocrinology and metabolism

Published: June 12, 2020

An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies.

An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies.

Journal: Pituitary

Published: March 30, 2020

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice.

Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice.

Journal: BMC endocrine disorders

Published: February 16, 2020

Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider.

Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider.

Journal: Pituitary

Published: December 07, 2019

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.

Development of a novel patient-reported measure for acromegaly: the Acro-TSQ.

Journal: Pituitary

Published: September 16, 2019

Patients with Acromegaly Presenting with Colon Cancer: A Case Series.

Patients with Acromegaly Presenting with Colon Cancer: A Case Series.

Journal: Case reports in endocrinology

Published: September 27, 2016

INCIDENCE AND PREVALENCE OF ACROMEGALY IN THE UNITED STATES: A CLAIMS-BASED ANALYSIS.

INCIDENCE AND PREVALENCE OF ACROMEGALY IN THE UNITED STATES: A CLAIMS-BASED ANALYSIS.

Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists

Published: August 20, 2016

Showing 1-12 of 27

Last Updated: 09/26/2026